Follow
2cureX AB
Nasdaq First North GM (Sweden)
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency mainly for cancer patients. It is involved in developing product namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and kidney cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Exercise
Price
0.10-28.88 SEK
Exercise period(s)
26 Apr - 07 May 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
2CUREX
SE0010468124
Nasdaq First North GM
Sweden (SE)
Details of share in 2cureX AB with ticker 2CUREX
Status
Active
Order book id
Amount of instruments
14 846 000
Par value
Currency
SEK
Segment
First North
First trading date
24 Oct 2017
Type
Price
Pre-money
Time
Files
IPO
7.80 SEK
62.4M SEK
13 Oct - 27 Oct 2017
IPO in 2cureX AB
Type
Price
Pre-money
Time
Files
Rights issue
11.95 SEK
123.68M SEK
09 May - 23 May 2019
Share issue in 2cureX AB
Type
Price
Pre-money
Time
Files
Directed issue
16.50 SEK
204.9M SEK
06 Jul 2020
Share issue in 2cureX AB
Type
Ticker
ISIN
Market
OPTION
2CUREX TO1
SE0014684494
Nasdaq First North GM
Sweden (SE)
Details of option in 2cureX AB with ticker 2CUREX TO1
Status
Active
Order book id
200508
Amount of instruments
2 455 000
Currency
SEK
Segment
First North
Trading period
06 Aug 2020 - 05 May 2021
Terms
For every ten (10) owned shares in the Company on the record date (17.07.2020), one (1) warrant of series TO1 will be received. Each warrant of series TO1 will give the holder the right to subscribe for one (1) new share at a subscription price corresponding to 70 percent of the average volume-weighted share price according to Nasdaq First North Growth Market’s official price statistics during the period from April 9, 2021 to April 22, 2021.
Update (13.07.2020): Record date for allotment of warrants of series TO1 is set to July 17, 2020.
Update (04.08.2020): First day for trading in TO1 series warrants.
Type
Price
Pre-money
Time
Files
Exercise
0.10-28.88 SEK
26 Apr - 07 May 2021
Option exercise terms for 2CUREX TO1
People
Fernando Andreu
CEO
Povl-Andre Bendz
Chairman of the board
Ole Thastrup
Board member
Jørgen Drejer
Board member
Juan Farré
Board member
Simon Hesse Hoffmann
Board member
Timm Jessen
Board member
Ulrich Spengler
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Fruebjergvej 3
Zip code
2100
City/district
Copenhagen
Country
Denmark (DK)
Registration number
559128-0077
LEI code
549300SFOL75WIYF2O80
First trade date
24 Oct 2017
Registration date
05 Oct 2017
Short name
2cureX

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More